ORGANIC
LETTERS
2010
Vol. 12, No. 20
4438-4441
Palladium-Catalyzed Amination of
Unprotected Halo-7-azaindoles
Jaclyn L. Henderson, Sarah M. McDermott, and Stephen L. Buchwald*
Department of Chemistry, Room 18-490, Massachusetts Institute of Technology,
Cambridge, Massachusetts 02139, United States
Received August 16, 2010
ABSTRACT
Simple and efficient procedures for the Pd-catalyzed cross-coupling of primary and secondary amines with halo-7-azaindoles(pyrrolo[2,3-
b]pyridine) are presented. Previously, no general method was available to ensure the highly selective reaction of the heteroaryl halide in the
presence of the unprotected azaindole N-H. Using palladium precatalysts recently reported by our group, such reactions are easily accomplished
under mild conditions that can be applied to cross-coupling reactions with a wide array of aliphatic and aromatic amines.
Azaindoles have been receiving increased attention from the
pharmaceutical and agrochemical industries over the past
decade, due both to their potential as indole-isosteres and as
interesting core structures in their own right.1,2 The substitu-
tion of a carbon by a nitrogen not only confers altered
electronic properties but also adds a potential hydrogen bond
acceptor, which can form the basis for altering the physi-
cochemical or biological properties of a compound.3 The
close proximity of hydrogen bond donor and acceptor sites
also distinguishes azaindoles as important substructures in
dyes, ligands for transition metals, and novel materials.2,4
Despite their utility, methods for the synthesis and
functionalization of azaindole scaffolds remain limited. The
majority of methods provide N-1, C-2, or C-3 substituted
structures, with few offering general solutions to function-
alization of the pyridine ring.2,5-7 A particularly interesting
subset of these molecules are amino-substituted azaindoles,
which appear in a variety of biologically active molecules
(Figure 1)8-12 and can be particularly challenging or lengthy
to prepare Via reported methods. Amino-7-azaindoles are
often accessed from the corresponding halide Via SNAr
displacement reactions, which typically require high tem-
peratures, extended reaction times, and a large excess of the
amine partner.13 Furthermore, 5-haloazaindoles are not
suitable substrates for SNAr, nor are some amines. Alternative
approaches employ the amino-substituted azaindole as the
key intermediate, which can be challenging to prepare.14
Our approach to the synthesis of amino-azaindoles is to
use Pd-mediated cross-coupling technology15-18 for the
(8) Blake, J.; Gunawardana, I. W.; Le, H. Y.; Mohr, P. J.; Wallace,
E. M.; Wang, B. Pyrrolo[2,3-b]pyridines as CHK1 and CHK2 kinase
inhibitors for the treatment of Various diseases and preparation thereof.
Patent WO 2009089352, 2009
.
(9) Mortimore, M.; Young, S. C.; Everitt, S. R. L.; Knegtel, R.; Pinder,
J. L.; Rutherford, A. P.; Durrant, S.; Brenchley, G.; Charrier, J. D.;
O’Donnell, M. Preparation of 5-cyano-4-(pyrrolo[2,3-b]pyridin-3-yl)pyri-
(1) Lednicer, D. Strategies for Organic Drug Synthesis and Design, 2nd
midines as polo-like kinase (PLK) inhibitors. Patent WO2008/79346 , 2008.
ed.; Wiley: Hoboken, 2009
(2) Popowycz, F.; Routier, S.; Joseph, B.; Merour, J. Y. Tetrahedron
2007, 63, 1031–1064
.
(10) Ruggeri, S. G.; Hawkins, J. M.; Makowski, T. M.; Rutherford, J. L.;
Urban, F. J. Process for preparation of piperidinylaminopyrrolopyrimidines
from actiVated pyrrolopyrimidines and piperidinylamines. Patent WO
.
(3) Kulagowski, J. J.; Broughton, H. B.; Curtis, N. R.; Mawer, I. M.;
Ridgill, M. P.; Baker, R.; Emms, F.; Freedman, S. B.; Marwood, R.; Patel,
S.; Ragan, C. I.; Leeson, P. D. J. Med. Chem. 1996, 39, 1941–1942.
2007012953 A2, 2007.
(11) Heinrich, T.; Blaukat, A.; Staehle, W.; Greiner, H.; Kordowicz,
M. NoVel aza heterocycles serVing as kinase inhibitors. Patent WO
(4) Hudson, Z. M.; Wang, S. Acc. Chem. Res. 2009, 42, 1584–1596
.
2006114180, 2006.
(5) Merour, J. Y.; Joseph, B. Curr. Org. Chem. 2001, 5, 471–506
(6) Song, J. J.; Reeves, J. T.; Gallou, F.; Tan, Z. L.; Yee, N. K.;
Senanayake, C. H. Chem. Soc. ReV. 2007, 36, 1120–1132
(7) Prokopov, A. A.; Yakhontov, L. N. Pharm. Chem. J. 1994, 28, 30–
.
(12) Choshi, T.; Yamada, S.; Sugino, E.; Kuwada, T.; Hibino, S. J. Org.
Chem. 1995, 60, 5899–5904
.
.
(13) Caldwell, J. J.; Cheung, K. M.; Collins, I. Tetrahedron Lett. 2007,
48, 1527–1529.
51
.
(14) Schneller, S. W.; Luo, J. K. J. Org. Chem. 1980, 45, 4045–4048.
10.1021/ol101928m 2010 American Chemical Society
Published on Web 09/22/2010